WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Structure Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | WELLINGTON MANAGEMENT GROUP LLP | 23,309,313 13.950% | 10,192,335 (+77.70%) | Filing |
| 2024-02-08 10:03 am Sale | 2023-12-29 | 13G | Structure Therapeutics Inc. GPCR | WELLINGTON MANAGEMENT GROUP LLP | 13,116,978 9.430% | -2,763,258 (-17.40%) | Filing |
| 2024-02-06 11:01 am Purchase | 2024-01-31 | 13G | Structure Therapeutics Inc. GPCR | WELLINGTON MANAGEMENT GROUP LLP | 15,880,236 11.410% | 15,880,236 (New Position) | Filing |